Search

Search Constraints

You searched for: Author/Creator Goodwin, Rachel

Search Results

1. A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229). (16th August 2019)

2. Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study. Issue 12 (December 2022)

4. Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. (June 2016)

5. Oral magnesium supplements for cancer treatment‐induced hypomagnesemia: Results from a pilot randomized trial. Issue 4 (14th December 2021)